Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2006

Hayes Vanessa M, Severi Gianluca, Southey Melissa C, Padilla Emma J D, English Dallas R, Hopper John L, Giles Graham G, Sutherland Robert L

Abstract excerpt

Macrophage inhibitory cytokine-1 (MIC-1), a member of the transforming growth factor-beta superfamily, is important in regulating inflammation. Inflammation of the prostate has been suggested to favor tumor development. A recent study (JNCI 2004, 96:1248-1254) found marginal evidence of an associ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Australia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Cytokines

Share to DNA, Neoplasm

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 16775185
DOI: 10.1158/1055-9965.EPI-06-0063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-16775185-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival.PMID 16775185Read ↗

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.Semantic proximity Read ↗

MIC1 and IL1RN genetic variation and advanced prostate cancer risk.Semantic proximity Read ↗

Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.Semantic proximity Read ↗

Interleukin-6 promoter variants, prostate cancer risk, and survival.Semantic proximity Read ↗

Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.Semantic proximity Read ↗

Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.Semantic proximity Read ↗

Interleukins-6 -174G/C (rs1800795) and -572C/G (rs1800796) polymorphisms and prostate cancer risk.Semantic proximity Read ↗

Interleukin-6 -572G/C polymorphism and prostate cancer susceptibility.Semantic proximity Read ↗

MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.Semantic proximity Read ↗

The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo.Semantic proximity Read ↗

Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.Semantic proximity Read ↗

Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.